UnknownNot Applicable

SLNB After Nipple Sparing Mastectomy

Turkey (Türkiye)20 participantsStarted 2019-11

Plain-language summary

Sentinel Lymph Node Biopsy (SLNB) after nipple sparing mastectomy (NSM) is controversial. This study aims to investigate feasibility of SLNB with radioisotope method.

Who can participate

Age range18 Years – 70 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: NSM with/without SLNB at least 6 months prior to this study - Exclusion Criteria: previous axillary dissection and active breast cancer \-

What they're measuring

Enhancement in axilla

Timeframe: 4 hours after injection

Trial details

NCT IDNCT04140188

SponsorAcibadem University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-04

Contact for this trial

Halil KARA

+905326073933 halil.kara@acibadem.edu.tr

View on ClinicalTrials.gov More Sentinel Lymph Node Biopsy trials